Search by Drug Name or NDC
NDC 61958-1503-01 Sovaldi 200 mg/1 Details
Sovaldi 200 mg/1
Sovaldi is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is SOFOSBUVIR.
MedlinePlus Drug Summary
Sofosbuvir is used along with ribavirin (Copegus, Rebetol, Ribasphere, others) and sometimes another medication (peginterferon alfa [Pegasys]) to treat certain types of chronic hepatitis C (an ongoing viral infection that damages the liver) in adults. Sofosbuvir is also used along with ribavirin to treat certain types of chronic hepatitis C (an ongoing viral infection that damages the liver) in children 3 years of age and older. Sofosbuvir is in a class of antiviral medications called nucleotide polymerase inhibitors. It works by decreasing the amount of hepatitis C virus (HCV) in the body. Sofosbuvir may not prevent the spread of hepatitis C to other people.
Related Packages: 61958-1503-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Sofosbuvir
Product Information
| NDC | 61958-1503 |
|---|---|
| Product ID | 61958-1503_d0b160ff-8146-4893-86f0-1925fcd67ad9 |
| Associated GPIs | 12353080000310 |
| GCN Sequence Number | 080163 |
| GCN Sequence Number Description | sofosbuvir TABLET 200 MG ORAL |
| HIC3 | W5Y |
| HIC3 Description | HEP C VIRUS,NUCLEOTIDE ANALOG NS5B POLYMERASE INH |
| GCN | 46869 |
| HICL Sequence Number | 040795 |
| HICL Sequence Number Description | SOFOSBUVIR |
| Brand/Generic | Brand |
| Proprietary Name | Sovaldi |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SOFOSBUVIR |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | SOFOSBUVIR |
| Labeler Name | Gilead Sciences, Inc. |
| Pharmaceutical Class | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], RNA Replicase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA204671 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61958-1503-01 (61958150301)
| NDC Package Code | 61958-1503-1 |
|---|---|
| Billing NDC | 61958150301 |
| Package | 28 TABLET, FILM COATED in 1 BOTTLE (61958-1503-1) |
| Marketing Start Date | 2019-08-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |